Sleep Movement Disorders Market

Future Market Insights

Key Insight

The sleep movement disorders market is projected to grow from USD 1.2 billion in 2025 to USD 2.1 billion by 2035, at a CAGR of 6.0%. Dopaminergic Agonists will dominate with a 35.0% market share, while restless legs syndrome will lead the sleep movement disorder type segment with a 40.0% share.

October 14, 2025

Anurag Sharma

275 Pages

Cite this Report

Sleep Movement Disorders Market

https://www.futuremarketinsights.com/reports/sleep-movement-disorders-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
BlackRock
Bristol-Myers Squibb
Eli Lilly and Company
Merck KGaA
L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Sleep Movement Disorders Market

Key Players

Similar Industry Reports